Logotype for Ingersoll Rand Inc

Ingersoll Rand (IR) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Ingersoll Rand Inc

Q3 2024 earnings summary

17 Jan, 2026

Executive summary

  • Achieved record Q3 2024 orders of $1,799M (up 10%) and revenues of $1,861M (up 7%) year-over-year, with over 200 basis points of adjusted EBITDA margin expansion and 9% adjusted EPS growth, despite challenging macro conditions.

  • Free cash flow margin reached 20% ($374M), and the company remains on track for double-digit adjusted EPS growth and strong free cash flow for 2024.

  • Closed 15 M&A transactions year-to-date, exceeding annual inorganic revenue targets, with 10 more deals under LOI, mainly bolt-ons, and record annualized inorganic growth in 2024.

  • Major acquisitions, including ILC Dover, expanded the Precision and Science Technologies segment and contributed to revenue and profit growth.

  • Divested asbestos-related liabilities, resulting in a $58.8 million pre-tax loss and removal of all related obligations from the balance sheet.

Financial highlights

  • Q3 2024 revenue: $1,861M, up 7% year-over-year; orders: $1,799M, up 10% year-over-year; gross margin improved by 130 bps to 43.8%.

  • Adjusted EBITDA was $533M (28.6% margin), up 15% year-over-year; adjusted EPS was $0.84, up 9% year-over-year; net income was $222M.

  • Free cash flow for Q3 was $374M (20% margin); operating cash flow was $404M; capex was $30M.

  • Total liquidity at $4.0B, with $1.4B cash on hand and $2.6B revolving credit facility; leverage at 1.7x, up 0.8x year-over-year due to ILC Dover acquisition.

  • Book-to-bill ratio at 0.97 for Q3; expected to be approximately 1 for full year.

Outlook and guidance

  • Full-year 2024 revenue guidance revised to $7,195M–$7,330M (5–7% growth); adjusted EPS guidance narrowed to $3.28–$3.34 (up 11–13% year-over-year).

  • Organic revenue growth guidance lowered to (2)%–0% for both total company and segments, due to order shipment timing.

  • Adjusted EBITDA guidance for 2024 is $2,010M–$2,040M (up ~13% year-over-year at midpoint); M&A expected to contribute $455M in 2024.

  • No changes to guidance on interest expense, tax rate, CapEx, or free cash flow conversion.

  • Sufficient liquidity is anticipated to fund obligations, working capital, and capital spending.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more